{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:10:42Z","timestamp":1790856642754,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Greek Research Infrastructure for Personalised Medicine","award":["MIS 5002802"],"award-info":[{"award-number":["MIS 5002802"]}]},{"name":"Operational Programme \u2018Competitiveness, Entrepreneurship and Innovation\u2019","award":["NSRF 2014\u20132020"],"award-info":[{"award-number":["NSRF 2014\u20132020"]}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Pathogenesis of antiphospholipid syndrome (APS) remains poorly elucidated. We aimed to evaluate for the first time kidney transcriptome profiles in primary APS vs systemic lupus erythematosus (SLE) and control subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed RNA sequencing on archival formalin-fixed paraffin-embedded kidney biopsies from APS (n\u2009=\u20094), SLE (n\u2009=\u20095) and control (n\u2009=\u20093) individuals, differential gene expression analysis (DGEA) and enrichment analysis using gene ontology (GO) and CORUM, KEGG and Reactome pathway databases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Two-dimensional projection showed a distinct gene profile in primary APS vs control kidneys samples, but similar to SLE. DGEA in APS vs controls returned 276 upregulated and 217 downregulated genes, while the comparison between APS and SLE identified 75 upregulated and 111 downregulated genes. In 276 upregulated genes, enriched GO terms were (innate) immune response, inflammatory response, leucocyte and lymphocyte activation, cytokine production and T cell activation. CORUM and KEGG revealed complement-related genes (C3, C4A, C4B). Expression levels showed logFC values of 2.25 (P\u2009=\u20091.58e-05) for C3, 2.17 (P\u2009=\u20092.69e-06) for C4A and 2.135 (P\u2009=\u20093.7e-06) for C4B in APS vs controls, without differences between APS and SLE. Interferon (IFN) alpha\/beta signalling was revealed by Reactome. Expression levels of nine IFN-regulated genes found upregulated in APS vs control kidneys (P-values\u2009\u2264\u20090.001 for all). Examining neutrophil-extracellular traps (NETs)-related gene expression, 13 of 15 upregulated NETs-related genes exhibited higher expression in APS vs controls but not vs SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Complement, interferon and NETs-related genes are highly expressed in APS kidney tissues, similarly to SLE, pointing out the role of innate immunity in APS nephropathy pathogenesis and potential treatment targets.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae397","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T04:51:28Z","timestamp":1723006288000},"page":"3184-3190","source":"Crossref","is-referenced-by-count":17,"title":["Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-0975","authenticated-orcid":false,"given":"Maria G","family":"Tektonidou","sequence":"first","affiliation":[{"name":"First Department of Propaedeutic and Internal Medicine, Joint Academic Rheumatology Program, \u2018Laiko\u2019 General Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleio-Maria","family":"Verrou","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic and Internal Medicine, Joint Academic Rheumatology Program, \u2018Laiko\u2019 General Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]},{"name":"Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikleia","family":"Gakiopoulou","sequence":"additional","affiliation":[{"name":"First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menelaos","family":"Manoloukos","sequence":"additional","affiliation":[{"name":"Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Lembessis","sequence":"additional","affiliation":[{"name":"Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Hatzis","sequence":"additional","affiliation":[{"name":"Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]},{"name":"Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming , Vari,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-2930","authenticated-orcid":false,"given":"Petros P","family":"Sfikakis","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic and Internal Medicine, Joint Academic Rheumatology Program, \u2018Laiko\u2019 General Hospital, School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]},{"name":"Centre of New Biotechnologies and Precision Medicine (CNBPM), School of Medicine, National and Kapodistrian University of Athens , Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"2024110419214105600_keae397-B1","doi-asserted-by":"crossref","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"key":"2024110419214105600_keae397-B2","doi-asserted-by":"crossref","first-page":"SI14","DOI":"10.1093\/rheumatology\/kead575","article-title":"New advances in genomics and epigenetics in antiphospholipid syndrome","volume":"63","author":"L\u00f3pez-Pedrera","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419214105600_keae397-B3","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2024110419214105600_keae397-B4","doi-asserted-by":"crossref","first-page":"109735","DOI":"10.1016\/j.clim.2023.109735","article-title":"Antiphospholipid syndrome nephropathy: current knowledge and unanswered questions","volume":"255","author":"Xourgia","year":"2023","journal-title":"Clin Immunol"},{"key":"2024110419214105600_keae397-B5","doi-asserted-by":"crossref","first-page":"e000924","DOI":"10.1136\/rmdopen-2019-000924","article-title":"Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"5","author":"Tektonidou","year":"2019","journal-title":"RMD Open"},{"key":"2024110419214105600_keae397-B6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3899\/jrheum.2022-1200","article-title":"Efforts to better characterize \u2018antiphospholipid antibody nephropathy\u2019 for the new antiphospholipid syndrome classification criteria: renal pathology subcommittee report","volume":"51","author":"Barbhaiya","year":"2024","journal-title":"J Rheumatol"},{"key":"2024110419214105600_keae397-B7","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.20433","article-title":"Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long term outcome","volume":"50","author":"Tektonidou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2024110419214105600_keae397-B8","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024110419214105600_keae397-B9","doi-asserted-by":"crossref","first-page":"102978","DOI":"10.1016\/j.jaut.2022.102978","article-title":"Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome","volume":"134","author":"Verrou","year":"2023","journal-title":"J Autoimmun"},{"key":"2024110419214105600_keae397-B10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/biology10070665","article-title":"FLAME: a web tool for functional and literature enrichment analysis of multiple gene lists","volume":"10","author":"Thanati","year":"2021","journal-title":"Biology."},{"key":"2024110419214105600_keae397-B11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/BOR.0000000000000926","article-title":"An update on inflammation in antiphospholipid syndrome (APS)","volume":"35","author":"Ambati","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"2024110419214105600_keae397-B12","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3389\/fimmu.2020.02063","article-title":"Excessive neutrophils and neutrophil extracellular traps in COVID-19","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"2024110419214105600_keae397-B13","doi-asserted-by":"crossref","first-page":"SI4","DOI":"10.1093\/rheumatology\/kead603","article-title":"Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?","volume":"63","author":"Raschi","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419214105600_keae397-B14","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2009-01-199117","article-title":"Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies","volume":"114","author":"Seshan","year":"2009","journal-title":"Blood"},{"key":"2024110419214105600_keae397-B15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/jcm10040626","article-title":"Expanding the role of complement therapies: the case for lupus nephritis","volume":"10","author":"Li","year":"2021","journal-title":"J Clin Med"},{"key":"2024110419214105600_keae397-B16","doi-asserted-by":"crossref","first-page":"102311","DOI":"10.1016\/j.jaut.2019.102311","article-title":"Type I interferon gene expression in antiphospholipid syndrome: pathogenetic, clinical and therapeutic implications","volume":"104","author":"Xourgia","year":"2019","journal-title":"J Autoimmun"},{"key":"2024110419214105600_keae397-B17","doi-asserted-by":"crossref","first-page":"ard-2024-225664","DOI":"10.1136\/ard-2024-225664","article-title":"Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events","volume":"12","author":"Nikolopoulos","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2024110419214105600_keae397-B18","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1136\/annrheumdis-2016-210485","article-title":"Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use","volume":"75","author":"van den Hoogen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024110419214105600_keae397-B19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11926-020-00936-1","article-title":"NETs in APS: current knowledge and future perspectives","volume":"22","author":"Ajay","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2024110419214105600_keae397-B20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2022.05.001","article-title":"Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome","volume":"214","author":"Mazetto","year":"2022","journal-title":"Thromb Res"},{"key":"2024110419214105600_keae397-B21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ndt\/gfy125","article-title":"Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare","volume":"34","author":"Mejia-Vilet","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2024110419214105600_keae397-B22","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/rheumatology\/keac641","article-title":"Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations","volume":"62","author":"Mavragani","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419214105600_keae397-B23","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ekir.2024.03.014","article-title":"Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis","volume":"9","author":"Parodis","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2024110419214105600_keae397-B24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41584-024-01123-7","article-title":"Can transcriptomics guide the management of SLE-associated APS?","volume":"20","author":"Knight","year":"2024","journal-title":"Nat Rev Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae397\/58777266\/keae397.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/3184\/60415477\/keae397.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/3184\/60415477\/keae397.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T19:21:57Z","timestamp":1730748117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/11\/3184\/7728460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,8,6]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae397","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,8,6]]}}}